Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice.
Escudero-Vilaplana V, Collado-Borrell R, Del Monte-Millán M, Hoyo-Muñoz A, Gómez Martínez-Sagrera P, Revuelta-Herrero JL, Marzal-Alfaro B, Gonzalez-Haba E, López-Tarruella Cobo S, Jerez Gilarranz Y, Herranz A, Sanjurjo M, Martin M.
Escudero-Vilaplana V, et al.
Support Care Cancer. 2021 Aug;29(8):4673-4681. doi: 10.1007/s00520-021-06016-z. Epub 2021 Jan 28.
Support Care Cancer. 2021.
PMID: 33506273